Across TCGA pan-cancer cohorts, OR7E31P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR7E31P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where OR7E31P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR7E31P is over-expressed in tumor.

BLCA, UCEC, and STAD are the cancer types where OR7E31P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR7E31P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.038	.022	3	view →
UCEC	All	All	+0.036	.037	2	view →
STAD	All	II,III,IV	+0.040	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: OR7E31P RNA expression & survival · all OR7E31P data types